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Abstract
Salmonella enterica serovars are responsible for the life-threatening, fatal, 
invasive diseases that are common in children and young adults. According to the 
most recent estimates, globally, there are approximately 11–20 million cases of 
morbidity and between 128,000 and 161,000 mortality per year. The high incidence 
rates of diseases like typhoid, caused by the serovars Typhi and Paratyphi, and 
gastroenteritis, caused by the non-typhoidal Salmonellae, have become worse, with 
the ever-increasing pathogenic strains being resistant to fluoroquinolones or almost 
even the third generation cephalosporins, such as ciprofloxacin and ceftriaxone. 
With vaccination still being one of the chosen methods of eradicating this disease, 
identification of candidate proteins, to be utilized for effective molecular vaccines, 
has probably remained a challenging issue. In our study here, we portray the usage 
of computational tools to analyze and predict potential vaccine candidate(s) for the 
multi-drug resistant serovars of S. enterica.
Keywords: typhoid, Salmonella Typhi, multidrug resistance,  
computational identification, vaccine candidates
1. Introduction
With a current worldwide prevalence of around twenty-seven million cases  
[1, 2] and hundreds of thousands of deaths every year [2, 3], salmonellosis remains 
the second most common food/water-borne illness. It constitutes a disease caused 
due to the systemic infection of human and animal hosts by the facultatively 
anaerobic, Gram-negative rod-shaped bacterial species of Salmonella enterica from 
the family Enterobacteriaceae. Clinically, several serologic variants (serovars) of 
S. enterica exist, which differ with respect to their different antigenic variation in 
lipopolysaccharide and flagella [4, 5]. They include Typhi and Paratyphi A, besides 
the non-typhoidal serotypes like Typhimurium and Enteriditis [4]. Among these, 
the enteric fever termed typhoid, caused by S. Typhi and Paratyphi, is typically a 
more severe illness than those caused by other non-typhoidal serovars [5].
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Being contagious in nature, salmonellosis, like typhoid, can spread through 
feces, water and the hands of those caring for the sick while, for non-typhoidal 
serovars, through the consumption of raw or undercooked contaminated food 
of animal origin such as meat, poultry, eggs and milk by humans [1, 6, 7]. 
Salmonellosis begins with ingestion of a dose for the bacterium enough to broach 
the first-line host defenses and colonize the gastrointestinal tract. The onset symp-
toms for typhoid are usually accompanied with fever, headache, myalgia, anorexia 
and sometimes diarrhea or constipation [6, 7], moving onto remittent fever, with 
a stepwise increment in the daily peak temperature, reaching 40°C by the end 
of the first week [6]. Slow recovery after 3–4 weeks is the normal case, though, 
for untreated patients with complications, major fatalities occur due to intestinal 
hemorrhage or perforation [6, 7].
Drugs available for the treatments are mostly ineffective due to the resistance 
developed with the emergence of multidrug-resistance (MDR) Salmonella strains 
[8]. These new strains are ineffective to the older generations of drugs including 
ampicillin, chloramphenicol, ciprofloxacin, trimethoprim as well as co-trimoxazole 
and their derivatives, thereby necessitating the newer classes of cephalosporins and 
quinolone derivatives to be greatly explored to combat such MDR threats [1, 8]. 
Moreover, dating as early as the 1890s, whole-cell vaccines with parenteral adminis-
tration of killed suspensions of S. Typhi [9] has several problems having: a) high-
reactivity with 20–25% fever and 40–50% local reactions, b) moderate efficacy 
with protection rates of 51–88% insufficient to halt disease transmission in endemic 
area and c) logistical and safety problems having the need for needles and two 
doses. Approaches with recent vaccines, like, single-dose Typhim Vi® containing 
purified Vi capsular polysaccharide, or, the live attenuated vaccine S. Typhi Ty21a 
(Vivotif®), confer around 50% protection in adults, and very poor immunogenicity 
among young children, without any license for under two years old, besides being 
considered to be expensive for low-middle income areas [10, 11]. Thus, the urgency, 
for new and specific vaccines and/or drugs to combat the disease, is evident and 
indeed, proteins of the pathogen-specific biochemical and biosynthetic pathways, 
involved in the virulence of S. Typhi, has already begun to be targeted with a view 
to developing novel vaccines/drugs.
While the two afore-mentioned vaccines are for S. Typhi, those for other 
serovars including Paratyphi, Typhimurium and Enteritidis were largely unavail-
able until some few years back [11]. Of late, efforts to confer protective immunity 
for serovars of Typhimurium has been reported with the lppA and lppB Braun 
lipoprotein genes with and without the msbB gene, encoding an acetyltransferase 
enzyme required for modification of the lipid A of lipopolysaccharide [12]. Other 
candidate genes proposed for effective vaccines for different serovars include rpoS, 
phoPQ, ssaV, htrA [13], besides the proteins of SseBI, OmpACDFL and SopB being 
used as antigens in other vaccination studies [14]. Such recombinant attenuated 
Salmonella vaccines (RASV) are considered to be same or more effective than the 
whole wild-type strains [15]. RASV can persistently colonize internal lymphoid 
tissues to produce recombinant antigens having their maximum abilities to elicit 
mucosal and systemic antibody along with those of the cell mediated immune 
responses [15]. Thus, development of such recombinant vaccines is considered to 
be the cost-effective and most promising strategy against the pressing antibiotic 
resistance threats. In this regard, several strategies have been adopted in other 
drug resistant bacteria including reverse vaccinology through comparative genome 
analysis and in vitro proteomics [16, 17]. These become especially effective keeping 
in mind the new and emerging threats of multidrug resistance strains of Salmonella. 
Such strains might possibly arise form immune selection leading to antigen 
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sequence variability followed by a down-regulation of the target antigens, thereby 
conferring poor “cross-protective efficacy” as reported for MDR Acinetobacter 
baumannii [18]. Therefore, identification of new and effective vaccine candidates is, 
probably, the current need of the hour.
With an availability of different virulent proteins, reported from different 
experimental verification and predictive databases, selection of the most plausible 
vaccine candidates can be confusing. To cater to the need of simplifying this com-
plex problem of selection, graph theoretical analysis of the interacting networks of 
such virulent proteins, involved in the disease scenario, might be poised to be quite 
useful. Such virulent protein interaction networks (PIN) can be utilized to find out 
the most central or sought-after proteins for such cases [19]. Ideally, the centrality 
of any biological networks is efficiently analyzed through global parameters like 
betweenness, closeness, degree and eigen-vector centralities, referred to as the BC, 
CC, DC and EC, respectively [19–21]. Among them, BC has been regarded to be 
efficient enough to impart central character of a network above CC and DC for long 
until EC gained some prominence and can be quite effective as reported through 
recent studies [22–25].
In this study, we proposed the vaccine candidates for Salmonella serovars 
(Figure 1) as explained in the next section. Essentially, we utilized the four dif-
ferent centrality measures for analyzing three different virulent PINs denoted 
as VVaDK, VFDF and VFDX. Among the top 20 rankers of each of the different 
centralities, the unanimously present unique candidates were finally collected for 
further downstream analyses. These shortlisted candidate virulent proteins were 
rigorously analyzed through different bioinformatic tools to determine their anti-
genic and allergenic potential besides revealing the epitopes for efficient vaccines or 
molecular crevices for good drug targets.
2. Approach
2.1 Dataset collection
We have initiated our study with the proteins collected for Salmonella enterica 
serovar Typhimurium str. LT2 (NCBI txid: 99287) on the 19th of December 2020. 
Figure 1. 
Graphical summary of the methods adopted in vaccine candidates and druggability prediction. This 
comprises a network-based approach to identify the key players in Salmonella virulent proteome coupled with 
downstream predictions of vaccine candidates and druggable pockets among the top rankers.
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They were retrieved from two different sources namely, the National Center for 
Biotechnology Information (NCBI) and the Virulence Factor Database (VFDB) [26]. 
From NCBI, protein datasets were collected through literature search using various 
keywords such as Virulence, Virulence Factor, Virulence Protein, Drug(s), Vaccine(s) 
and Key. Some of these keywords, having essentially the same meaning, were used 
to get more hits and to avoid missing of any possible candidates thereby reducing the 
false-negative hits. Finally, all the candidates of the lists were merged, and duplicates 
were removed to yield 120 proteins to be considered for further analysis. They were 
termed as VVaDK for easy reference, where V stands for Virulence, Va represents 
Vaccine(s), D means Drug(s) and K denotes Key. Moreover, two types of candidates’ 
lists were retrieved from VFDB. They comprised the Full dataset which covers all the 
proteins (261) related to unknown and predicted VFs of S. Typhimurium and were 
referred as VFDF. Additionally, 117 experimentally verified candidates were retrieved 
for S. Typhimurium and termed as VFDX.
All the afore-mentioned proteins for the different categories of VVaDK, VFDF 
and VFDX were fed as queries to the biological meta-database of protein interac-
tion, STRING version 11.0 [27] to retrieve all the possible interactions of a par-
ticular protein [date and time of access: Dec 22, 2020, from 17 hours IST onwards]. 
Detailed protein links file under the accession number 90371 in STRING v11 was 
used to collect all the interactions of the whole genome proteins of S. Typhimurium. 
In each case, a database dictated default medium confidence value of 0.4, for the 
combined scores from different parameters of interaction, was used. Accordingly, 
the total number of protein interactions obtained were 138, 3501 and 2464 for 
VVaDK, VFDF and VFDX listed candidates, respectively.
2.2 Interactome construction
The protein interaction data for all individual sets for VVaDK, VFDF and VFDX, 
having medium confidence values, were imported into Cytoscape version 3.8.2 
[28] to integrate and build the respective interactomes of protein interactions. Care 
was taken to remove duplicate and bidirectional interactions from each dataset. 
In essence, such interactome of proteins or the protein interaction network (PIN) 
has been constructed as an undirected graph, G = (V, E), consisting of E edges and 
a finite set of V vertices (or nodes) where, edge, e = (u, v), is connected to two 
vertices u and v. Each vertex/node in our PIN represents a protein. The number 
of connections/interactions/associations/links, a protein has with other proteins, 
reflects its degree, d [29].
2.3 Network analysis
All the constructed 3 PINs have been viewed by Cytoscape v 3.8.2 in the form of 
interactomes of aforementioned interconnected proteins. They were subsequently 
analyzed through the integrated java plugin CytoNCA version 2.1.6 [30] to com-
pute values for BC, CC, DC and EC as the four different global network centrality 
parameters. The different parametric combined scores from STRING were consid-
ered as edge weights for computing the CytoNCA scores of the 4 centrality param-
eters. Upon sorting these 4 measures from largest to smallest, top 20 proteins for 
each of the categories of centrality were picked to create Venn diagrams using Venny 
2.0 [31] for finding the common proteins from each of the measures. This resulted 
in 12, 10, 7 proteins from VVaDK, VFDF and VFDX, respectively. Among these 29 
candidates, 9 duplicates were removed to yield a total of 20 proteins. Through a 
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BLASTp alignment, these Typhimurium proteins were unanimously found in the 
serovars of Typhi and Paratyphi, and thus, considered for further analyses.
2.4 Vaccine and/or drug candidature prediction
2.4.1 Basic analysis
The 20 shortlisted protein candidates from VVaDK, VFDF and VFDX PIN 
analysis were subjected to further analyses for predicting the plausible vaccine 
and/or drug candidates. All such proteins were explored for their molecular weight 
calculation, cellular localization, signal peptide prediction followed by antigenicity 
prediction. ProtParam was used to find the molecular weight and number of amino 
acids [32] and cellular localization was analyzed by PSORTb v3.0.2 [33]. Location of 
signal peptides was predicted using the server called SignalP 4.1 [34]. Lipoprotein 
signal peptides were predicted using the LipoP 1.0 [35]. Finally, Vaxijen was used to 
predict the possible antigenicity of the proteins [36].
2.4.2 Mapping of available 3D structures in PDB
For the top ranked proteins, the respective crystallized protein 3D structures 
available in Protein Data Bank (PDB) were retrieved (Table 1). The seleno-methi-
onine in PDB structures were changed back into methionine using Dock Prep in 
Chimera [37].
Protein Structural Information
PDB ID Chain ID Structure Coverage Resolution
SptP 1G4W R 161–543 2.20
1JYO E 35–139 1.90
SpaO 4YX1 A 232–297 1.35
4YX7 A 145–213 2.00
4YX7 B 232–297 2.00
PrgH 4G1I A 170–392 1.85
4G2S A 11–119 1.86
6UOT A 1–392 3.30
SipB 3TUL A 81–237 2.79
SsrB 2JPC A 133–193 (First 19 N-terminal amino  
acids missing)
NMR
SctC 4G08 A 22–178 1.80
6PEE A 1–562 3.42
PrgK 6UOT Y 1–252 3.30
4OYC A 96–200 2.60
SiiE 2YN5 A 5078–5365 1.85
SsaQ, SsaD, InvE, HilA, BcfD, SicA, SsaJ, SscA, DD95_23890, DD95_21695, DD95_16310, and DD95_14775 
have no structures available in PDB.
Table 1. 
PDB structure availability among top rankers.
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2.4.3 B-cell epitope prediction
Unlike viral pathogens, most bacterial pathogens are not intracellular parasites, 
especially Salmonella. Thus, the humoral immune response, which involves B 
cells and antibodies, will be of great focus in this study. Herein, BepiPred v2.0 
and DiscoTope v2.0 were utilized in predicting linear and discontinuous B-cell 
epitopes, respectively [38, 39]. For BepiPred, the default threshold score of 0.5 was 
applied for epitope recognition. For DiscoTope, the propensity score radius was 
22 Angstrom, upper half sphere radius was 14 Angstrom, window size was 1, and 
alpha was 0.115. An in-house script (DiscoTope2ChimeraAttr) has been utilized 
to convert DiscoTope result into Chimera attributes for visualization in 3D, with 
a default threshold DiscoTope score of −3.7 [40]. These analyses were done to 
pinpoint the specific immunogenic regions within the full-length proteins. Thus, 
the immunogenically insignificant regions can be trimmed out, resulting in shorter 
peptides which can confer higher specificity and ease the peptide synthesis process.
2.4.4 Allergenicity prediction
The ability of proposed immunogen to potentially evoke allergic reactions can 
usually fail clinical trials due to the severe adverse effects arising upon vaccination. 
Herein, we utilized AllerCatPro, AlgPred2, and AllergenFP v1.0 to predict possible 
allergic reactions raised by the query proteins, which were the top rankers in this 
case. For AlgPred2, the hybrid algorithm was selected and the default threshold 
value of 0.3 was selected. AllerCatPro predicts allergenicity by comparing the 
protein structural and sequential information to known allergens [41]. Besides, the 
hybrid algorithm of AlgPred2.0 utilizes the random forest, BLAST, and MERCI 
algorithms to predict the allergenicity of the query proteins [42]. Moreover, the 
allergenicity prediction of AllergenFP v1.0 utilizes an alignment-independent 
fingerprint-based approach [43].
2.4.5 Druggable pocket prediction
P2Rank was being utilized to predict the presence of druggable pockets in the 
available 3D structures of proteins [44]. P2Rank utilizes a template-independent 
machine learning algorithm in predicting potential ligand-binding sites on the 
query proteins. Herein, the topmost ranked predicted pockets were selected for 
further analyses. Thus, besides being utilized in vaccination, the potential drug-
gability of the top rankers can be discovered.
2.4.6 Detecting human counterparts
Peptide vaccines that contain regions of high sequence similarity to human 
proteome counterparts can lead to ineffective vaccination due to recognition as 
“self” by the immune system, which can result in low antigenicity or adverse effects 
that arise from potential self-reactivity. Thus, the top rankers were screened for 
human counterparts via sequence alignment approach using BLASTp against non-
redundant proteins (nr) database with Homo sapiens as the specified organism [45].
3. Interactome analyses of three virulent PINs
Three different interactomes of virulent proteins of Salmonella were built using 
the method described above. The first of them comprised those available through 
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literature search using different keywords comprising Virulence, Virulence Factor, 
Virulence Protein, Drug(s), Vaccine(s) and Key. This was named as VVaDK. The 
other two PINs were made of the full and experimentally verified datasets of viru-
lent proteins from Salmonella, listed in VFDB and were named as VFDF and VFDX, 
respectively. The four centrality measures were applied for analyzing each of these 
PINs and twenty top rankers from each of the measures were initially segregated. 
Among them, the proteins present unanimously for all the measures were noted as 
12, 10 and 7 for VVaDK, VFDF and VFDX, respectively, and a removal of duplicates 
from them finally yielded 20 candidates for further downstream analysis.
Our unique way of streamlining the candidates is based upon the following 
facts. Under pathological conditions, the virulent proteins are expected to be 
working in unison to render the final disease phenotype. Thus, their connectivity 
could be perceived in terms of the said PINs. Among these proteins, some can be 
master regulators and connecting to others more frequently thereby having higher 
order of connectivity. This renders them degree centrality (DC). Alternatively, 
there could be different types of such regulators for carrying out different sub-
functions of the main disease phenotype and they form the bridge between the 
other proteins. These could impart the betweenness centrality (BC) of such pro-
teins. Moreover, among such conglomerate of different proteins, certain numbers 
could connect to others faster to sequentially carry out their function, leading 
to a concept of closeness for them and having higher closeness centrality (CC). 
Furthermore, certain proteins could be more important to render the final disease 
phenotype and they are only connected to other important proteins to carry out 
their functions. These could bring out their character of eigen vector centrality 
(EC). Finally, from the top-ranking proteins of all these centrality measures, those, 
appearing unanimously, are expected to play a major role in virulence and could 
be segregated to scan for further analysis. These are 20 unique virulent proteins, 
mostly belonging to the Salmonella Pathogenicity Islands (SPI) from three differ-
ent PIN analyses and reflected in Figure 1 and Table 2. These are discussed in the 
next section.
4. Features of the twenty virulent proteins
All the virulent proteins from different serovars of Salmonella are discussed 
here, with their characteristic features along with a note on their existing vaccine 
potential.
SptP is one of the most important SPI-1 Type III Secretion System (T3SS) 
effector proteins which facilitates the bacterial translocation and survival into 
the host non-phagocytic cells by inhibition of the extracellular-regulated kinase 
(ERK) mitogen-activated protein kinase (MAP) pathways [46]. It requires SicP as a 
chaperone protein for its secretion and stabilization [46]. Moreover, SptP is directly 
responsible for the reversal of the actin cytoskeletal changes in the host cells by act-
ing as a GTPase-activating protein (GAP) for Rac-1 and Cdc42. In fact, the efficacy 
of sptP deletion mutation of S. Enteriditis has been shown to be effective for live 
attenuated vaccine (LAV) in chickens [47].
SsaQ is a member of FliN/YscQ/Spa33/HrcQ family of both T3SS and flagellum 
proteins [48]. The gene ssaQ is encoded in the ssaMVNOPQ operon within the SPI-2 
and transcribes to two products namely, SsaQL of 322 residues and SsaQS of 106 
residues. SsaQS acts as a chaperone-like protein for SsaQL and optimize its func-
tion. SsaQ interact with SsaK and SsaN to form the C-ring complex, which have a 
crucial role in secretion by acting as a cytoplasmic sorting platform at the base of 
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# of TM Helices Position Score (Orientation)
SptP 543 60047.68 E — 0.5192 A 1 477–496 570 (o-i)
SsaQ 322 36009.35 C — 0.3857 NA 1 186–209 611 (i-o)
SpaO 303 33793.74 C — 0.5073 A 1 62–86 600 (o-i)
PrgH 392 44459.53 C — 0.5122 A 1 142–163 2551 (o-i)




SsaD 403 44849.66 CM — 0.4319 A 1 119–135 2978 (o-i)




HilA 553 63040.96 C — 0.3985 N 1 340–361 523 (o-i)
BcfD 335 35928.51 U SP(SPI):
21–22




SsrB 212 24354.49 C — 0.4053 A 0 — —
SctC 562 61765.81 OM SP(SPI):
24–25
0.371 N 1 5–25 1725 (i-0)
SicA 165 19220.72 C — 0.5954 A 0 — —
SsaJ 249 28521.47 U LIPO(SPII):
18–19




SscA 157 18134.88 C — 0.3731 N 0 — —
PrgK 252 28210.3 OM LIPO(SPII):
17–18
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DD95_23890
(BigA)


















788 87222.97 E — 0.382 N 0 — —
DD95_16310
(TorS)








147 16757.61 U — 0.4706 A 1 127–144 1622 (o-i)
TM: Transmembrane. For Localization, E: Extracellular, C: Cytoplasmic, CM: Cytoplasmic Membrane, OM: Outer Membrane, U: Unknown. For TMpred status, A: Antigen, N: Non-antigen.
Table 2. 
Basic screening of plausible vaccine candidates.
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SpaO is a major invasion factor of S. enterica spp. and the core component of 
the sorting platform in S. Typhimurium. SpaO is comprised of 303 residues of two 
translated products with SpaOS (the shorter product) encompassing the last 101 
amino acids of SpaOL (full length protein) [50]. It is a highly conserved element in 
T3SS that shares similarity with limited residues with flagellar C-ring substructure 
[51]. In fact, SpaO, along with H1a, has been suggested to be promising new vaccine 
candidates to prevent typhoid fever caused by S. Paratyphi A infection [52].
PrgH is a 55 kDa protein encoded within prgHIJK operon in the SPI-1. All the 
genes of prg operon are essential for the formation of T3SS needle complex (NC) 
and known to share sequence similarity with the flagellar protein, FliF [53]. PrgH 
inserts in the inner membrane by its hydrophobic domain where it forms the 
MS-ring of the flagellar basal body as well as provides the structural foundation 
required for prgK oligomerization for further assembly of the NC [53].
SicA is a wide acting chaperone protein (18 KDa) which aids in the secretion 
process of all T3SS proteins through the invasion of host cells. Accordingly, it is 
encoded upstream to the Sip/SspABCD operon in SPI-1. SipB and SipC proteins 
are responsible for the translocon formation in the host cell membrane to facilitate 
the injection of Type III effector proteins into the host cell to manipulate it [54]. 
Moreover, SicA is essential for the expression of the most virulence genes that 
encode T3SS effector proteins and is identified as a co-regulator with InvF for 
SigDE and SptP [55].
HilA is a member of the OmpR/ToxR regulator protein family and the central 
activator of SPI-1 genes, belonging to T3SS. The hilA gene is encoded within 
SPI-1 and is the key factor in SPI-1-T3SS regulation, starting from the expression 
of downstream genes sicA and invF to ultimate regulation of the effector genes 
sipA and sipB [56]. The upregulation of hilA results in the high expression of all 
genes encoded within the SPI-1 which are necessary for the invasion of epithelial 
cells. Moreover, the expression of hilA is controlled by many different activators 
and suppressors in response to specific environmental changes during invasion 
of the host cells, such as, temperature, bile, fatty acids, osmolarity, pH, oxygen 
concentrations and growth state [57]. Additionally, certain studies considered 
HilA as a promising drug target to inhibit the activity of T3SS without affecting 
the growth of Salmonella [58].
SiiE is the largest protein in Salmonella proteome, with the size of 595 kDa. 
It consists of 53 repetitive bacterial immunoglobulin domains, each containing 
several conserved residues [59]. The protein helps to contact the host cell mem-
brane and positions the SPI T3SS, to initiate the translocation of effector proteins. 
A study states that Salmonella SiiE-mediated entry of enterocytes via the apical 
route requires transmembrane mucin MUC1 [60]. Moreover, it is shown that, siiE 
is required for the prevention of efficient humoral immune response against the 
pathogen and it induces the high tires of specific Salmonella-specific IgG [61].
PrgK is a component from the inner membrane of Salmonella SPI-1 T3SS basal 
body, in its N-terminus. It possess the canonical lipoproteins which acts as anchor 
for the hydrophilic proteins onto the surface of the bacterial cell membranes [62]. 
In addition, C-terminus of PrgK is found in the cytoplasm which confirms that the 
protein traverses the inner membrane. A study observed reduced fever in swine 
which were vaccinated with prgK gene attenuated S. Typhimurium in comparison 
with mock-vaccinated swine [63].
SscA is a chaperone protein of about 18 KDa size. It is an independent α-helical 
protein, that consists of eight α-helices and repeated large tetratricopeptide domain 
from 36 to 137 amino acids. SscA is a virulence factor which encodes the chapero-
nin of SseC and the translocon is involved during the adaptation and survival to 
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desiccation [64]. A huge effect of the gene expression level of sscA, has been noted 
on treatment of the samples with ciprofloxacin [65].
SsaJ is a core encoding component of the T3SS. It is required for SpvB, in-order 
to induce the actin depolymerization, especially inside the human macrophages. 
Salmonella depends on SsaJ effector protein as it prevents the interaction of NADPH 
oxidase subunit Cytb558 with the Salmonella containing vesicle (SCV) thereby 
helping to avoid the oxidative burst [66]. An in vivo study, conducted with the 
peptide of SsaJ, however, showed its inability to provide antigen specific immunity 
when compared with the other chosen peptides [67].
SctC is a layer of outer membrane anchor forming two distinct outer rings 
namely, OR1 and OR2. It is homologous to a protein of Type II Secretion System 
(T2SS) which requires pilotin lipoprotein for its optimal assembly and localization 
[68]. SctC serves as a midline between the inner and outer membrane, with evi-
dence showing that the translocation of foreign antigens can induce potent immune 
response against pathogens [69].
SsrB is responsible for the survival and replication of Salmonella in the host cell 
and plays an important role in the transcription of multiple genes of SPI-2. SsrB has 
been claimed as one of the most important factors for Salmonella’s virulence by the 
fact that, a mutated ssrB, resulted in reduced ability of colonization on comparing 
with the wild type [70]. Moreover, one alteration in the gene ssrB, preferentially 
silencing the acquired DNA, can have a high contribution towards low transcription 
in the virulence factors of Salmonella [71].
BcfD is a fimbrial protein and part of the operon Bcf [72]. BcfD is a surface mol-
ecule, which helps in the adherence through specific receptors on the host cell. This 
step of adhesion is considered to be an important course during infection as it allows 
bacteria to initiate the colonization [73]. A research shows that the knockout of this 
gene influenced in the low adhesion capacity of Salmonella to the host cell [74].
InvE, encoded within SPI-1, is a protein located in the cell membrane and said to 
be essential for the translocation of Salmonella proteins into the host cells by regulat-
ing the functions of the Sip protein translocases [75]. An investigation of finding the 
region of InvE, as the T3SS regulator protein, indicates that it may have two func-
tional domains which are responsible for regulating the secretion of translocases as 
N-terminal secretion signal and C-terminal regulatory domain [76]. An in-vivo study 
conducted with the BALB/c mice, showed less pathogenicity when it is injected with 
the mutated invE gene Salmonella on comparing with the wild strain [77].
SipB is one of the effector proteins of SPI-1 T3SS which facilitates the entry of 
Salmonella into the host cell. It is also called as an invasion protein as it initiates the 
bacterial entry process. It forms a complex along with the SipC to assemble into 
plasma membrane-integral structure which mediates the effectors delivery [78]. It 
also affects the membrane fluidity and bacterial osmotolerance and hence a small 
alteration of this gene will pave a huge way to prevent Salmonella entry into the 
host cell [79]. In fact, a study evaluating the effect of sipB deleted mutants, showed 
significant decrease in the virulence of sipB mutants when compared with the wild-
type strains [80].
SsaD is an important cellular component which is responsible for the virulence 
of Salmonella. It is found to be in the transmembrane of the bacteria. The gene ssaD 
encodes for the proteins related to the basal body, cytoplasmic rings and export appa-
ratus and it is also involved in the ATPase complex, regulation and translocation of 
T3SS [81]. A study shows that there is an important defect in the intercellular survival 
with the mutant ssaD strains on comparing with the wild-type Salmonella [82].
DD95_23890 refers to the computationally predicted protein, mapping to the 
autotransporter adhesin BigA protein. The BigA protein in Salmonella has recently 
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12
been identified via automated genome annotation in 2015. Thus, studies on this 
protein has been scarce. Inferring from its homolog in Brucella, the cell surface BigA 
protein promotes adhesion of bacteria on host epithelial cells [83, 84]. The adhesive 
properties of the BigA protein can be established by binding onto the cell adhesion 
molecules on the host epithelial cellular surface [85].
DD95_21695 maps to the RING-type E3 ubiquitin transferase (SspH2) protein. 
The SspH2 protein aids in Salmonella pathogenicity by conferring anti-inflamma-
tory properties, hence delaying the host immune response in reaction to bacterial 
invasion [86]. Moreover, the ability of SspH2 to ubiquitinate host NOD1 protein, 
through an essential interaction with host SGT1 protein, can result in NOD1-
mediated IL-8 secretion in host [87].
DD95_16310 maps to the Salmonella TorS histidine kinase sensor. The TorS 
protein comprises the two-component systems along with the TorT response regu-
lator [88]. Upon stimulation by Trimethylamine-N-oxide, TorS, along with TorT, 
carry out osmoregulation and protect the cellular proteins against low-pH induced 
denaturation in urea [88].
DD95_14775 refers to the putative transcriptional regulator marT_1 in 
Salmonella. The MarT protein mainly regulates the expression of MisL autotrans-
porter protein, which is a fibronectin-binding protein that is involved in the cell 
adhesive properties of Salmonella [89]. Moreover, MarT has also been reported to 
regulate the expression of genes related to bacterial biofilm formation [90].
5. Initial screening of the candidate proteins
All the twenty proteins were screened to ascertain their potential for plausible can-
didatures as vaccines (Table 2). Proteins were localized in extracellular matrix (3), 
cytoplasm (7), cytoplasmic membrane (3) and outer membranes (2), besides some 
of them being predicted with unknown cellular location (5). Of these, surface/outer 
membrane proteins and vesicles have been deployed for prospective vaccinations 
against bacterial pathogens [91–94]. Again, extracellular proteins have been potenti-
ated as drugs for prospects against disease management, albeit, in a different scenario 
[95, 96]. Our results predict the proteins namely, SptP, SipB, SsaD, PrgK and TorS 
to be potentially antigenic except InvE, SctC and SspH2. Notably, the five proteins 
of unknown location, namely, BcfD, SsaJ, BigA, SiiE, and MarT_1 are all potentially 
antigenic. Of the two signal peptides BcfD and SctC, the latter was predicted to be 
non-antigenic while SsaJ and PrgK belongs to another category of signal peptides 
(lipoproteins) with good antigenic potential. Of these, SsaJ has been predicted with 
two transmembrane (TM) spanning helices and poses itself a good candidate for 
vaccines. Other candidates with more TM helices are BigA (5), SiiE (3) and TorS (3). 
Furthermore, a BLASTp alignment of these 20 proteins revealed SptP and SspH2 to 
have 40–50% similarity for 101 and 106 hits, respectively, against human counter-
parts, thereby completely ruling out their candidature as potential vaccines.
6. Selection of potential vaccine candidates
The 20 top ranked proteins were further screened for B cell epitopes.  
Therein, InvE, SsrB, SicA, and SscA were omitted from being considered as vac-
cine candidates due to the absence of predicted epitopes that fall within the normal 
range of peptide length (Table 3). Moreover, in allergenicity prediction, HilA, 
BcfD, SicA, BigA, SiiE, and MarT_1 were predicted to be potential allergens  
(Table 4), and thus, were excluded from consideration as well. Hence, we report 
SptP, SsaQ, SpaO, PrgH, SipB, SsaD, SctC, SsaJ, PrgK, SspH2, and TorS to be 
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Protein Start End Peptide Length Average 
Score
SptP 5 25 EERKLNNLTLSSFSKVGVSND 21 0.5922
59 78 FKNTEVVQKHTENIRVQDQK 20 0.5383
378 396 EDQMQAKQLPPYFRGSYTF 19 0.5593
SsaQ 5 23 ANEERPWVEILPTQGATIG 19 0.5839
58 75 WQRWCEGLIGTANRSAID 18 0.5467
93 113 ASDATLCQNEPPTSCSNLPHQ 21 0.5675
SpaO 21 37 ECQRHGREATLEYPTRQ 17 0.5256
PrgH 84 104 LHELKEGNSESRSVQLNTPIQ 21 0.5941
115 138 ESEPWVPEQPEKLETSAKKNEPRF 24 0.6261
164 182 NSPQRQAAELDSLLGQEKE 19 0.5371
261 277 SRQRNTMSKKELEVLSQ 17 0.5634
SipB 5 22 ASSISRSGYTQNPRLAEA 18 0.5777
232 253 GTANAASQNQVSQGEQDNLSNV 22 0.5356
545 569 MDQIQQWLKQSVEIFGENQKVTAEL 25 0.5389
SsaD 18 38 GHVLQGREVWLNEGNLSLGEK 21 0.5384
155 170 LDKSNIHYVRAQWKED 16 0.5236
257 274 IPGLLHWQISHSHQSQGD 18 0.5234
331 345 QDIAPSHDESKYLPA 15 0.5794
HilA 206 227 VKGYHLLHQESIKLIEHQPASL 22 0.5358
242 256 GLRWDTKQISELNSI 15 0.5672
BcfD 121 144 PMNNVLMGYDENVKAGQPFYVRDS 24 0.5932
214 232 LYSGNFNHAGQKPEGVRAK 19 0.6014
282 303 NALIPNDVQSVAPFITDSAGRA 22 0.5514
SctC 430 449 DGNDKTPQSDTTTSVDALPE 20 0.6323
SsaJ 20 34 DVDLYRSLPEDEANQ 15 0.5328
91 111 NQLVVSPQEEQQKINFLKEQR 21 0.5596
PrgK 20 34 DKDLLKGLDQEQANE 15 0.5634
188 207 SERSDAQLQAPGTPVKRNSF 20 0.5906
229 249 YYKNHYARNKKGITADDKAKS 21 0.6077
BigA 1429 1448 RVLSNRFTMLADAAPQIKDG 20 0.5452
1456 1475 KGDPRAELGNDTQYDMLALR 20 0.5380
1689 1709 SSNDTALHLDAYQWKEDGISD 21 0.5748
SspH2 72 95 FELLRTLAYAGWEESIHSGQHGEN 24 0.5541
431 446 RNQLTRLPESLIHLSS 16 0.5176
574 594 TEATSSCEDRVTFFLHQMKNV 21 0.5220
620 639 FRLGKLEQIAREKVRTLALV 20 0.5312
TorS 133 148 TLRAQQQQLSRQIAEA 16 0.5421
172 192 AGIYDLIESGKGDQAERALDR 21 0.5473
663 677 SKPASKSAFREPINL 15 0.5645
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potentially utilized as B cell epitopes. Moreover, in discontinuous B cell epitope 
prediction, the localizations of the highly antigenic regions were illustrated in 3D 
(Figure 2). For successful vaccination, these regions should be prioritized and 
retained as much as possible due to their important roles in antigenicity.
7. Potential druggable proteins
Besides potential vaccine candidates, we have conducted predictions on the 
druggability and druggable sites of the 20 top ranked proteins which have their 
3D crystallized structures available in PDB. Eventually, the localization of the top 
Protein Start End Peptide Length Average 
Score
MarT_1 106 126 ITIIATDSETKGRKKQIVRQT 21 0.5981
Only predicted peptides of length between 15 to 25 amino acids were selected [97]. SiiE protein were omitted from 
prediction because of its overly huge sequence.
Table 3. 
BepiPred v2.0 prediction of linear B-cell epitopes.
Protein AllerCatPro AlgPred2 AllergenFP v1.0
Hybrid Score Prediction
SptP No Hits 0.04 Non-Allergen Probable Non-Allergen
SsaQ No Hits 0.08 Non-Allergen Probable Non-Allergen
SpaO No Hits 0.03 Non-Allergen Probable Non-Allergen
PrgH No Hits 0.03 Non-Allergen Probable Non-Allergen
SipB No Hits 0.24 Non-Allergen Probable Non-Allergen
SsaD No Hits 0.09 Non-Allergen Probable Non-Allergen
InvE No Hits 0.02 Non-Allergen Probable Non-Allergen
HilA No Hits 0.54 Allergen Probable Non-Allergen
BcfD No Hits 0.85 Allergen Probable Non-Allergen
SsrB No Hits −0.43 Non-Allergen Probable Non-Allergen
SctC No Hits 0.09 Non-Allergen Probable Non-Allergen
SicA No Hits 0.31 Allergen Probable Allergen
SsaJ No Hits −0.45 Non-Allergen Probable Non-Allergen
SscA No Hits 0.18 Non-Allergen Probable Non-Allergen
PrgK No Hits −0.48 Non-Allergen Probable Non-Allergen
BigA No Hits 0.75 Allergen Probable Non-Allergen
SiiE No Hits 0.86 Allergen N/A
SspH2 No Hits −0.48 Non-Allergen Probable Non-Allergen
TorS No Hits 0.02 Non-Allergen Probable Non-Allergen
MarT_1 No Hits 0.55 Allergen Probable Non-Allergen
For AllergenFP v1.0, N/A refers to Not Available because of overly large protein size.
Table 4. 
Allergenicity assessment through different predictive tools. Potential allergens are in bold case.
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ranked druggable pockets of SptP, SipB, SctC, SpaO, SsrB, PrgK, PrgH, and SiiE 
were illustrated in 3D (Figure 3). This can help future research in structure-aided 
drug discovery, by designing drugs specific for the druggable pockets to suppress 
the virulence of Salmonella.
8. Conclusions
The study depicted here essentially delineates a schematic approach of 
shortlisting the most probable virulent proteins as potential vaccine and/or drug 
candidates from the proteome of Salmonella spp. It starts with the building of the 
theoretical PIN comprising the known and predicted virulent proteins followed by 
the graph theoretical parametric analyses for identifying a probable set of them. 
These were further screened through different essential tools enabling the predic-
tion of cellular localisation, signal peptides, transmembrane helices, antigenicity, 
epitopes, allergenicity and molecular crevices besides comparing with any human 
homologs. A thorough analysis revealed SsaJ and PrgK to come to the forefront 
among those already known to be virulent. PrgK even has nice druggable pocket to 
be targeted through potential drugs. Our approach can pave the way for screening 
such effective molecular vaccines and/or drug targets for such pathogens. Newer 
candidates, however, could be unraveled through other effective methods.
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